Cargando…
Polypharmacy in the HIV-infected older adult population
The prevalence of human immunodeficiency virus (HIV) infection among people older than 50 years is increasing. Older HIV-infected patients are particularly at risk for polypharmacy because they often have multiple comorbidities that require pharmacotherapy. Overall, there is not much known with resp...
Autores principales: | Gleason, Lauren J, Luque, Amneris E, Shah, Krupa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693722/ https://www.ncbi.nlm.nih.gov/pubmed/23818773 http://dx.doi.org/10.2147/CIA.S37738 |
Ejemplares similares
-
Polypharmacy in older adults with HIV infection: Effects on the brain
por: Smith, Lauren, et al.
Publicado: (2021) -
Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women
por: Kim, Suk Chul, et al.
Publicado: (2013) -
Polypharmacy in Older Adults with Alzheimer’s Disease
por: Esumi, Satoru, et al.
Publicado: (2022) -
Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population
por: Gimeno-Gracia, Mercedes, et al.
Publicado: (2016) -
Evaluation of a Statewide HIV-HCV-STD Online Clinical Education Program by Healthcare Providers – A Comparison of Nursing and Other Disciplines
por: WANG, Dongwen, et al.
Publicado: (2016)